This DFM was previously validated against data obtained from both mouse fibroblasts transformed by oncogenic K-ras expression (NIH3T3 K-ras cells) and a human K-ras-mutated breast cancer cell line (MDA-MB-231) (Nobile et al., 2020). Here, KRAS is linked to breast cancer.